ASSURE HOLDINGS CORP (IONM)
US04625J3032 - Common Stock
We assign a fundamental rating of 2 out of 10 to IONM. IONM was compared to 117 industry peers in the Health Care Providers & Services industry. IONM may be in some trouble as it scores bad on both profitability and health. IONM is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IONM has reported negative net income.
In the past year IONM has reported a negative cash flow from operations.
In multiple years IONM reported negative net income over the last 5 years.
IONM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -251.76%, IONM is not doing good in the industry: 95.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -251.76% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IONM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
IONM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IONM has more shares outstanding
The number of shares outstanding for IONM has been increased compared to 5 years ago.
IONM has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -11.19, we must say that IONM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -11.19, IONM is not doing good in the industry: 87.07% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.19 |
ROIC/WACCN/A
WACC9.54%
2.3 Liquidity
IONM has a Current Ratio of 1.50. This is a normal value and indicates that IONM is financially healthy and should not expect problems in meeting its short term obligations.
IONM has a Current ratio of 1.50. This is comparable to the rest of the industry: IONM outperforms 58.62% of its industry peers.
A Quick Ratio of 1.50 indicates that IONM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.50, IONM is in the better half of the industry, outperforming 64.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The earnings per share for IONM have decreased strongly by -158.53% in the last year.
IONM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -83.94%.
Measured over the past years, IONM shows a decrease in Revenue. The Revenue has been decreasing by -7.02% on average per year.
EPS 1Y (TTM)-158.53%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q54.44%
Revenue 1Y (TTM)-83.94%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Revenue growth Q2Q-99.23%
3.2 Future
The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
IONM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.16% yearly.
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
IONM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IONM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IONM's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y24.9%
5. Dividend
5.1 Amount
IONM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ASSURE HOLDINGS CORP
NASDAQ:IONM (5/3/2024, 7:00:02 PM)
After market: 0.495 -0.01 (-2.06%)0.5054
-0.02 (-4.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.55M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -251.76% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-158.53%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y95.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-83.94%
Revenue growth 3Y-14.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y